“Patients with heart disease face a higher risk of adverse outcomes, including hospitalization and death, following [RSV] compared with the general population.”
Heidenreich et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: